CSL Behring
CSL Behring is a biopharmaceutical company, manufacturing plasma-derived, and recombination therapeutic products. The company is a combination of Behringwerke, founded in 1904 in Marburg, Germany by Emil von Behring, and the Commonwealth Serum Laboratories (CSL), established in Australia in 1916 to provide vaccines to the people of Australia, as well as other companies acquired since 2004.
Traded as | ASX: CSL |
|---|---|
| Industry | Biopharmaceutical, health care |
| Headquarters | King of Prussia, Pennsylvania |
Key people | Paul McKenzie, CEO and Managing Director of CSL Limited |
Number of employees | 27,000+ |
| Parent | CSL Limited |
| Website | www |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.